Cytokine abundance in placental tissues: Evidence of inflammatory activation in gestational membranes with term and preterm parturition, American Journal of Obstetrics and Gynecology, vol.181, issue.6, pp.1530-1536, 1999. ,
DOI : 10.1016/S0002-9378(99)70400-X
Preterm premature rupture of the membranes, Obstet. Gynecol, vol.101, pp.178-193, 2003. ,
Cytokines, Prostaglandins and Parturition???A Review, Placenta, vol.24, pp.33-46, 2003. ,
DOI : 10.1053/plac.2002.0948
A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes, American Journal of Obstetrics and Gynecology, vol.179, issue.5, pp.1248-1253, 1998. ,
DOI : 10.1016/S0002-9378(98)70141-3
Production of Matrix Metalloproteinase-9 in Lipopolysaccharide-Stimulated Human Amnion Occurs Through an Autocrine and Paracrine Proinflammatory Cytokine-Dependent System1, Biology of Reproduction, vol.67, issue.6, pp.1952-1958, 2002. ,
DOI : 10.1095/biolreprod.102.004721
Expression of Interleukin-10 in Human Gestational Tissues, Journal of the Society for Gynecologic Investigation, vol.4, issue.5, pp.247-253, 1997. ,
DOI : 10.1016/S1071-5576(97)00045-2
Interleukin-10, Annual Review of Immunology, vol.11, issue.1, pp.165-190, 1993. ,
DOI : 10.1146/annurev.iy.11.040193.001121
Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection, American Journal of Obstetrics and Gynecology, vol.173, issue.4, pp.1223-1227, 1995. ,
DOI : 10.1016/0002-9378(95)91358-0
The regulation of prostaglandin output from term intact fetal membranes byanti-inflammatory cytokines, Immunology, vol.150, issue.1, pp.124-133, 2000. ,
DOI : 10.1016/1043-4666(90)90018-O
Interleukin-10 Inhibition of Gelatinases in Fetal Membranes, Obstetrics & Gynecology, vol.98, issue.2, pp.284-288, 2001. ,
DOI : 10.1097/00006250-200108000-00018
Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors, Immunopharmacology, vol.47, issue.2-3, pp.127-162, 2000. ,
DOI : 10.1016/S0162-3109(00)00185-5
Cyclic AMP-specific PDE4 Phosphodiesterases as Critical Components of Cyclic AMP Signaling, Journal of Biological Chemistry, vol.278, issue.8, pp.5493-5496, 2003. ,
DOI : 10.1074/jbc.R200029200
URL : https://hal.archives-ouvertes.fr/inserm-00322006
PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization, Biochemical Journal, vol.370, issue.1, pp.1-18, 2003. ,
DOI : 10.1042/bj20021698
Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-and IL-6 release by endotoxin-stimulated macrophages, J. Immunol, vol.155, pp.4909-4916, 1995. ,
Differential regulation of human monocyte-derived TNF-and IL-1-by type IV cAMPphosphodiesterase (cAMP-PDE) inhibitors, J. Pharmacol. Exp. Ther, vol.272, pp.1313-1320, 1995. ,
The New Phosphodiesterase 4 Inhibitor Roflumilast Is Efficacious in Exercise-Induced Asthma and Leads to Suppression of LPS-Stimulated TNF-?? Ex Vivo, The Journal of Clinical Pharmacology, vol.323, issue.25, pp.297-303, 2002. ,
DOI : 10.1177/00912700222011328
The Selective Phosphodiesterase 4 Inhibitor RP 73-401 Reduced Matrix Metalloproteinase 9 Activity and Transforming Growth Factor-beta Release During Acute Lung Injury in Mice: The Role of the Balance Between Tumor Necrosis Factor-alpha and Interleukin-10, Journal of Pharmacology and Experimental Therapeutics, vol.301, issue.1, pp.258-265, 2002. ,
DOI : 10.1124/jpet.301.1.258
and Neutrophil Elastase, American Journal of Respiratory Cell and Molecular Biology, vol.27, issue.4, pp.487-494, 2002. ,
DOI : 10.1165/rcmb.4818
Pregnancy induces a modulation of the cAMP phosphodiesterase 4-con- formers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors, J. Pharmacol. Exp. Ther, vol.292, pp.817-823, 2000. ,
Anti-Inflammatory and Utero-Relaxant Effects in Human Myometrium of New Generation Phosphodiesterase 4 Inhibitors, Biology of Reproduction, vol.70, issue.2, pp.458-464, 2004. ,
DOI : 10.1095/biolreprod.103.023051
URL : https://hal.archives-ouvertes.fr/inserm-00321998
I. Organ Culture of Amniochorionic Membrane In Vitro, American Journal of Reproductive Immunology, vol.7, issue.3, pp.184-187, 1994. ,
DOI : 10.1111/j.1600-0897.1994.tb01112.x
[43] Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates, Methods Enzymol, vol.159, pp.457-470, 1988. ,
DOI : 10.1016/0076-6879(88)59045-6
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Analytical Biochemistry, vol.72, issue.1-2, pp.248-254, 1976. ,
DOI : 10.1016/0003-2697(76)90527-3
Interleukin-10 and transforming growth factor-?? inhibit amniochorion tumor necrosis factor-?? production by contrasting mechanisms of action: Therapeutic implications in prematurity, American Journal of Obstetrics and Gynecology, vol.177, issue.4, pp.803-809, 1997. ,
DOI : 10.1016/S0002-9378(97)70272-2
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2, Cell, vol.83, issue.3, pp.493-501, 1995. ,
DOI : 10.1016/0092-8674(95)90127-2
Modulation of Amnionic Adenylate Cyclase and cAMP Phosphodiesterase by Prostaglandins E<sub>1</sub> and F<sub>2α</sub>, Gynecologic and Obstetric Investigation, vol.37, issue.2, pp.77-82, 1994. ,
DOI : 10.1159/000292529
Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-?? responses, Proc. Natl. Acad. Sci. USA 99, pp.7628-7633, 2002. ,
DOI : 10.1016/S0140-6736(99)00442-0
Regulation of Cultured Human Chorion Cell Chemokine Production by Group B Streptococci and Purified Bacterial Products, American Journal of Reproductive Immunology, vol.34, issue.5, pp.264-268, 1996. ,
DOI : 10.1111/j.1600-0897.1996.tb00175.x
In vitro cytokine and prostaglandin production by amnion cells in the presence of bacteria, American Journal of Obstetrics and Gynecology, vol.176, issue.5, pp.981-984, 1997. ,
DOI : 10.1016/S0002-9378(97)70389-2
SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions, J. Pharmacol. Exp. Ther, vol.284, pp.420-426, 1998. ,
regulation: a cAMP and a PKA-independent mechanism, British Journal of Pharmacology, vol.160, issue.2, pp.257-268, 2004. ,
DOI : 10.1038/sj.bjp.0705927
Suppression of granulocyte/macrophage colony-stimulating factor release from human monocytes by cyclic AMP-elevating drugs: role of interleukin-10, British Journal of Pharmacology, vol.10, issue.1, pp.58-67, 2001. ,
DOI : 10.1038/sj.bjp.0704238
Stimulation of prostaglandin production from intact human fetal membranes by bacteria and bacterial products, Placenta, vol.19, issue.4, pp.301-306, 1998. ,
DOI : 10.1016/S0143-4004(98)90062-5
Prostaglandin concentrations in amniotic fluid of women with intra-amniotic infection and preterm labor, American Journal of Obstetrics and Gynecology, vol.157, issue.6, pp.1461-1467, 1987. ,
DOI : 10.1016/S0002-9378(87)80245-4
Cytokine and prostaglandin production by amnion cells in response to the addition of different bacteria, American Journal of Obstetrics and Gynecology, vol.178, issue.1, pp.50-53, 1998. ,
DOI : 10.1016/S0002-9378(98)70625-8
Critical Paracrine Interactions Between TNF-?? and IL-10 Regulate Lipopolysaccharide-Stimulated Human Choriodecidual Cytokine and Prostaglandin E2 Production, The Journal of Immunology, vol.170, issue.1, pp.158-166, 2003. ,
DOI : 10.4049/jimmunol.170.1.158
Effect of phosphodiesterase 4 inhibitors on NFAT-dependent cyclooxygenase-2 expression in human T lymphocytes, Cellular Signalling, vol.16, issue.12, pp.1363-1373, 2004. ,
DOI : 10.1016/j.cellsig.2004.04.002
CYCLOOXYGENASE 2 (COX-2) GENE ACTIVATION IS REGULATED BY CYCLIC ADENOSINE MONOPHOSPHATE, Shock, vol.13, issue.1, pp.41-45, 2000. ,
DOI : 10.1097/00024382-200013010-00008
Obligatory Role of Cyclic Adenosine Monophosphate Response Element in Cyclooxygenase-2 Promoter Induction and Feedback Regulation by Inflammatory Mediators, Circulation, vol.105, issue.23, pp.2760-2765, 2002. ,
DOI : 10.1161/01.CIR.0000018127.10968.34
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms, Clinical Science, vol.94, issue.6, pp.557-572, 1998. ,
DOI : 10.1042/cs0940557
Differential Regulation of Lipopolysaccharide-Induced Monocyte Matrix Metalloproteinase (MMP)-1 and MMP-9 by p38 and Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinases, The Journal of Immunology, vol.170, issue.12, pp.6244-6249, 2003. ,
DOI : 10.4049/jimmunol.170.12.6244
Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases., Journal of Clinical Investigation, vol.99, issue.5, pp.894-900, 1997. ,
DOI : 10.1172/JCI119254
Interleukin 10 suppression of monocyte prostaglandin H synthase-2: mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production, J. Biol. Chem, vol.269, pp.21322-21329, 1994. ,
Prostaglandin E2-dependent production of latent matrix metalloproteinase-9 in cultures of human fetal membranes, Molecular Human Reproduction, vol.6, issue.11, pp.1033-1040, 2000. ,
DOI : 10.1093/molehr/6.11.1033
Elevation of intracellular cAMP inhibits growth factormediated matrix metalloproteinase-9 induction and keratinocyte migration, Mol. Pharmacol, vol.58, pp.145-151, 2000. ,
Tocolysis: current controversies, future directions, Curr. Opin. Investig. Drugs, vol.5, pp.424-429, 2004. ,
Prostaglandin inhibitors in preterm labour, Best Practice & Research Clinical Obstetrics & Gynaecology, vol.17, issue.5, pp.731-744, 2003. ,
DOI : 10.1016/S1521-6934(03)00047-6
Phosphodiesterase-4 Inhibitors in the Treatment of Inflammatory Lung Disease, Drugs, vol.161, issue.23, pp.2575-2594, 2003. ,
DOI : 10.2165/00003495-200363230-00002
Correlation between selective inhibition of the cyclic nucleotide phosphodiesterases and the contractile activity in human pregnant myometrium near term, Biochemical Pharmacology, vol.38, issue.1, pp.9-15, 1989. ,
DOI : 10.1016/0006-2952(89)90142-1